One possible explanation of this difference among histological types is that there are alternative pathways of proteolytic reactions in tumour progression, and the pathway involving TADG-15 may correlate with some histological phenotypes including clear cell adenocarcinoma of the ovary. Here, ST14 is linked to ovarian clear cell adenocarcinoma.